Tirzepatide injection pen used to improve blood sugar control in type 2 diabetes. 5 mg dose.
Contains tirzepatide, a dual GIP/GLP-1 receptor agonist. Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Attributes
Product Content
How to Use:
• Inject subcutaneously once weekly in the abdomen, thigh, or upper arm, any time of day, with or without food.
• Starting dose is 2.5 mg weekly for 4 weeks (not a maintenance dose), then increased to 5 mg weekly.
• Further increases of 2.5 mg every 4+ weeks may be needed, up to a maximum of 15 mg weekly.
• Rotate injection sites with each dose.
The link to Mounjaro KwikPen 5mg 1 Prefilled Pen (Refrigerated) has been copied